- Trials with a EudraCT protocol (111)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
111 result(s) found for: Stress Reduction.
Displaying page 1 of 6.
| EudraCT Number: 2012-003072-39 | Sponsor Protocol Number: 41223 | Start Date*: 2012-11-27 | |||||||||||
| Sponsor Name:Academic Medical Center, University of Amsterdam | |||||||||||||
| Full Title: Oxytocin in PTSD: effectiveness as addition to Narrative Exposure Therapy | |||||||||||||
| Medical condition: Posttraumatic stress disorder | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2021-003154-23 | Sponsor Protocol Number: 1402-0030 | Start Date*: 2022-04-05 | |||||||||||
| Sponsor Name:Boehringer Ingelheim AB | |||||||||||||
| Full Title: A Phase II, 8-week-treatment, multicenter, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy, tolerability and safety of orally administered BI 1358894 in ... | |||||||||||||
| Medical condition: Post-Traumatic Stress Disorder (PTSD) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Completed) FI (Completed) PL (Completed) HR (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-002919-41 | Sponsor Protocol Number: 13-003-05-DE | Start Date*: 2016-12-19 | |||||||||||
| Sponsor Name:Cook MyoSite Incorporated | |||||||||||||
| Full Title: A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR with Placebo in Female Subjects with Stress Urinary Incontinence | |||||||||||||
| Medical condition: Female Stress Urinary Incontinence | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: DE (Completed) BE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2009-011797-15 | Sponsor Protocol Number: IC-01-01-4-003 | Start Date*: 2009-12-18 | |||||||||||
| Sponsor Name:Innovacell Biotechnologie AG | |||||||||||||
| Full Title: Skeletal muscle-derived cell implantation in female patients with stress urinary incontinence: a multicenter, randomized, parallel-group, placebo-controlled clinical study | |||||||||||||
| Medical condition: Stress urinary incontinence (SUI) in female patients with predominately intrinsic sphincter deficiency of moderate severity | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: DE (Completed) CZ (Completed) BG (Completed) PL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2010-021867-34 | Sponsor Protocol Number: IC-01-01-5-006 | Start Date*: 2011-12-07 | |||||||||||
| Sponsor Name:Innovacell Biotechnologie AG - Life Science Center Innsbruck | |||||||||||||
| Full Title: An open, multicenter study to evaluate the urodynamic properties of a local implantation of autologous skeletal muscle-derived cells (SMDCs) in female patients with stress urinary incontinence | |||||||||||||
| Medical condition: Stress urinary incontinence (SUI) in female patients with predominantly intrinsic sphincter deficiency of moderate severity (Grade 2 and Grade 3) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: SI (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2010-021871-10 | Sponsor Protocol Number: IC-01-01-05-004 | Start Date*: 2012-04-18 | |||||||||||
| Sponsor Name:Innovacell Biotechnologie AG - Life Science Center Innsbruck | |||||||||||||
| Full Title: A multicenter, randomized, double-blinded, parallel-group, placebocontrolled study to assess the efficacy and safety of skeletal muscle-derived cell implantation in female patients with stress urin... | |||||||||||||
| Medical condition: Stress urinary incontinence (SUI) of moderate severity (Grade 2 and Grade 3) in female patients | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: DE (Completed) CZ (Completed) BG (Completed) AT (Completed) IT (Completed) GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2021-003228-34 | Sponsor Protocol Number: OCMDKET | Start Date*: 2022-04-25 |
| Sponsor Name:Medical University of Vienna | ||
| Full Title: Ketamine therapy and its effects on stress on neuropsychological function under stress in obsessive-compulsive disorder | ||
| Medical condition: Obsessive-compulsive disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: AT (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-000956-25 | Sponsor Protocol Number: 15-06 | Start Date*: 2018-11-09 | |||||||||||
| Sponsor Name:Cook MyoSite, Incorporated | |||||||||||||
| Full Title: CELLEBRATE: An Adaptive, Two-Stage, Double-Blind, Stratified, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR with Placebo in Female Subjects with Stress Urinary Incontin... | |||||||||||||
| Medical condition: Female Stress Urinary Incontinence | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2007-003262-17 | Sponsor Protocol Number: AG-1-2007. | Start Date*: 2008-08-13 |
| Sponsor Name:University Hospital Magdeburg | ||
| Full Title: Impact of irbesartan on oxidative stress and C-reactive protein levels in patients with persistent atrial fibrillation | ||
| Medical condition: Blocking the angiotensin II type 1 receptor reduces systemic levels of oxidative stress markers and adhesion molecules compared to placebo in patients with persistent/permanent atrial fibrillation. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-004160-67 | Sponsor Protocol Number: Protocol F1J-MC-SBCT (a) | Start Date*: 2005-02-24 |
| Sponsor Name:Eli Lilly and Company Limited | ||
| Full Title: Effect of Duloxetine on Valsalva Leak Point Pressure and Quantitative Rhabdosphincter Electromyography Measures in Women with Stress Urinary Incontinence | ||
| Medical condition: stress urinary incontinence | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: GB (Completed) DK (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-002456-90 | Sponsor Protocol Number: 14060802 | Start Date*: 2015-02-13 |
| Sponsor Name:Stockholm Centre for Dependency Disorders, Department of Clinical Neuroscience, Karolinska Institutet | ||
| Full Title: Integrated Exposure-Based Therapy for Co-occurring Posttraumatic Stress Disorder and Alcohol Dependence: Effects of the FAAH inhibitor PF-04457845 on Extinction. A Randomized Controlled Trial. | ||
| Medical condition: Current Posttraumatic Stress Disorder (PTSD) and Current Alcohol Dependence | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: SE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2021-000874-28 | Sponsor Protocol Number: 1 | Start Date*: 2021-07-08 |
| Sponsor Name:Gyn.Dept, Aabenraa Hospital, Sygehus Sønderjylland | ||
| Full Title: Effect of 24 mg dexamethasone preoperatively on surgical stress, pain and recovery in robotic-assisted laparoscopic hysterectomy | ||
| Medical condition: robotic- assisted hysterectomy | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: DK (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-003739-62 | Sponsor Protocol Number: 2021-74835 | Start Date*: 2021-06-23 |
| Sponsor Name:University Medical Center Utrecht | ||
| Full Title: BOOSTCAMP: Boosting the endocannabinoid system before the treatment of anxiety symptoms | ||
| Medical condition: PTSD and anxiety disorders | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-001962-25 | Sponsor Protocol Number: BR1-142 | Start Date*: 2016-03-04 | |||||||||||
| Sponsor Name:Bracco Imaging S.p.A. | |||||||||||||
| Full Title: A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress Echocardiography with Dobutamine for the Diagnosis ... | |||||||||||||
| Medical condition: Suspected or known Coronary Artery Disease | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) BE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2010-024189-23 | Sponsor Protocol Number: DR-CR-NEU01S01 | Start Date*: 2011-08-31 | |||||||||||
| Sponsor Name:Weleda AG | |||||||||||||
| Full Title: Efficacy and safety of Neurodoron in patients with nervous exhaustion - a randomized, double-blind, placebo-controlled clinical trial | |||||||||||||
| Medical condition: nervous exhaustion (neurasthenia) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-003280-26 | Sponsor Protocol Number: IMB101-005 | Start Date*: 2020-11-09 | |||||||||||
| Sponsor Name:Imbria Pharmaceuticals, Inc. | |||||||||||||
| Full Title: A Dose-Ranging Pharmacodynamic Study to Evaluate the Effects of IMB-1018972 on Myocardial Energetics, Metabolism, and Function in Patients with Type 2 Diabetes | |||||||||||||
| Medical condition: Diabetic Cardiomyopathy (DbCM) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2005-000223-42 | Sponsor Protocol Number: ZiSe | Start Date*: 2005-10-31 |
| Sponsor Name:University Hospital Hamburg-Eppendorf, Psychiatry | ||
| Full Title: Effects of ziprasidone vs. placebo during the first four weeks of eight weeks sertraline treatment in patients with posttraumatic stress disorder (PTSD) | ||
| Medical condition: Post-traumatic Stress Disorder (PTSD) according to DSM-IV criteria | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-017537-21 | Sponsor Protocol Number: PHT/2009/36 | Start Date*: 2010-03-02 |
| Sponsor Name:Portsmouth Hospitals NHS Trust | ||
| Full Title: Oral thiamine (Vitamin B1) supplementation in subjects with type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled crossover trial assessing biophysical markers of endothelial fun... | ||
| Medical condition: Type 2 diabetes | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-004286-18 | Sponsor Protocol Number: HPA-PTSD-1 | Start Date*: 2008-08-05 |
| Sponsor Name:Central Institute of Mental Health | ||
| Full Title: Monocentric, Double-blind Placebo-Controlled, Randomized Cross-Sectional Clinical Trial of Hydrocortisone (10 and 30mg/d) in Outpatients with Posttraumatic-Stress- Disorder (PTSD) ... | ||
| Medical condition: Intrusions in patients with posttraumatic stress disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-002454-37 | Sponsor Protocol Number: RGHT000392 | Start Date*: 2007-07-20 |
| Sponsor Name:The Royal Group Hospitals Trust | ||
| Full Title: Prevention by HMGCoA reductase inhibition of ALI associated with one lung ventilation following oesophagectomy by a Reduction of Pulmonary vascular dysfunction and inflammation (Prevention-HARP) | ||
| Medical condition: Acute lung injury (ALI) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.